Pulmatrix, Inc. Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Pulmatrix, Inc. on April 29, 2022, covering events that occurred on April 28, 2022. The Company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "PULM".
Financial Metrics
This filing does not contain financial statements, revenue, profit, cash flow, margin, debt, or liquidity data. The report is limited to corporate governance amendments.
Material Changes
The Board of Directors approved an amendment to the Company's Bylaws effective April 28, 2022. The key change reduces the quorum requirement for stockholder meetings:
- Previous Requirement: A majority of voting power present in person or by proxy.
- New Requirement: One-third of the voting power present in person or by proxy.
- Scope: Applies to all meetings and separate class votes, unless a larger number is required by law or stock exchange rules.
Guidance, Outlook, and Risks
The filing contains no management commentary, financial guidance, outlook, or discussion of risks and contingencies. The amendment is intended to facilitate the conduct of stockholder meetings by lowering the threshold for a quorum.
Key Facts for Investor Verification
- Verify the effective date of the Bylaw amendment (April 28, 2022).
- Confirm the new quorum threshold is one-third of voting power.
- Review Exhibit 3.1 attached to the filing for the full text of the amended Bylaws.
- Note that this filing does not impact the Company's financial position or operating results.